A Retrospective Study on the Evaluation of Platelet Utilization Practices at a Tertiary Care Facility
Abstract
Objective: Platelets have a relatively brief shelf life of 5 days and are infrequently available. Periodic audit of blood component utilization is necessary to ensure that corrective measures are taken to increase the proper and rational utilization of each component. Aim: To study the transfusion practices of platelets in a tertiary care center.
Material and Methods: A retrospective analysis was conducted from January 2023 to December 2023. Demographics, indications, and appropriateness were assessed. Descriptive statistics, including frequencies, percentages, means, and standard deviations, were utilized.
Results: The total platelets utilized were 1206. A total of 368 patients received 1206 platelets, which accounted for 409 episodes of transfusion. The male-female ratio was 3:1. The maximum utilization of platelets was seen by the Department of Medicine, 550 (45.6%), followed by Emergency Medicine and Traumatology, 263 (21.8%), Surgery, 148 (12.2%), and Cardiovascular and Thoracic Surgery (CVTS), 94 (7.8%). The most common indication for platelet transfusion was acute bleeding, 85 (20.7%), acute febrile illness (malaria, dengue cases), 68 (16.6%), followed by DIC and Sepsis (9.0%), and hematological conditions, 35 (8.6%); 11.9% of episodes were pre-procedural, 65.7% were prophylactic, and 15.1% were therapeutic.
Conclusion: This retrospective assessment of platelet utilization has provided insight into our existing platelet preparation, utilization, and transfusion policies, helping us to promote evidence-based practices by aligning the established guidelines with transfusion practices.
Keywords
Full Text:
PDFReferences
Sonnekus PH, Louw VJ, Ackermann AM, Barrett CL, Joubert G, Webb MJ. An audit of the use of platelet transfusions at Universitas Academic Hospital, Bloemfontein, South Africa. Transfus Apher Sci 2014;51:44–52.
British Committee for Standards in Haematology. Blood transfusion task force. Guidelines for the use of platelet transfusions. Br J Haematol 2003;122:10–23.
Brandis K, Richards B, Ghent A, Weinstein S. A strategy to reduce inappropriate red blood cell transfusion. Med J Aust 1994;160:721–2.
Koh MB, Lee YS, Chay J. Appropriate blood component usage. ISBT Sci Ser 2011;6:249–56.
Murphy MF, Murphy W, Wheatley K, Goldstone AH. Survey of the use of platelet transfusions in centres participating in MRC leukaemia trials. Br J Haematol 1998;102:875–6.
Schlossberg HR, Herman JH. Platelet dosing. Transfus Apher Sci 2003;28:221–6.
Khanna MP, Hébert PC, Fergusson DA. Review of the clinical practice literature on patient characteristics associated with perioperative allogeneic red blood cell transfusion. Transfus Med Rev 2003;17:110–9.
Saran RK. Blood component preparation and uses. In: Transfusion medicine technical manual. 2nd ed. New Delhi: Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India; 2003.
National Health and Medical Research Council. Clinical practice guidelines–appropriate use of platelets summary card. [homepage on the Internet] Canberra: NHMRC; 2001. Available from: http://www.nhmrc.gov.au/_files_nhmrc/publications/attachments/nh34.pdf.
Verma A, Pandey P, Khetan D, Chaudhary R. Platelet transfusions in clinical practice at a multidisciplinary hospital in North India. Transfus Apher Sci 2008;39:29–35.
Greeno E, McCullough J, Weisdorf D. Platelet utilization and the transfusion trigger: a prospective analysis. Transfusion 2007;47:201–5.
Charlewood R. Platelet usage in seven New Zealand hospitals. NZBlood 2007:1-14.
Bhat AW, Aziz R, Ahmed CB, Ahmed SI. Utility of blood components in paediatric patients: An audit. Curr Pediatr Res 2012;16:61–3.
Chenna D, Shastry S, Baliga P. Use of platelet components: An observational audit at a tertiary care centre. Natl Med J India 2021;34:197–200.
Singla A, Bassi R, Bhardwaj K, Thakur K, Singh H. Audit of 1000 platelet transfusions at a tertiary care hospital of North India. Int J Sci Res 2017;6:74–7.
Saluja K, Thakral B, Marwaha N, Sharma RR. Platelet audit: Assessment and utilization of this precious resource from a tertiary care hospital. Asian J Transfus Sci 2007;1:8–11.
Eikenboom JCJ, van Wordragen R, Brand A. Compliance with prophylactic platelet transfusion trigger in haematological patients. Transfus Med 2005;15:45–8.
Strauss RG, Blanchette VS, Hume H, Levy GJ, Schloz L, Blazina JF, et al. National acceptability of American Association of Blood Banks Pediatric Hemotherapy Committee guidelines for auditing pediatric transfusion practices. Transfusion 1993;33:168–71.
Qureshi H, Lowe D, Dobson P, Grant-Casey J, Parris E, Dalton D, et al. National comparative audit of the use of platelet transfusions in the UK. Transfus Clin Biol 2007;14:509–13.
St Elsewhere’s NHS Foundation Trust. 2010 Re-audit of the use of platelets in haematology 2011. [monagraph on the Internet] Bristol: NHs; 2010. Available from: https://nhsbtdbe.blob.core.windows.net/umbraco-assets-corp/14930/nca-platelet_re-audit_report-st_elsewheres_nhs_foundation_trust_2010.pdf
Estcourt LJ, Birchall J, Lowe D, Grant-Casey J, Rowley M, Murphy MF. Platelet transfusions in haematology patients: Are we using them appropriately? Vox Sang 2012;103:284–93
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.